Alprazolam Extended-Release Tablets — Class II drug recall D-1091-2014
Terminated recall by Actavis Elizabeth LLC, reported 2014-03-12, distributed nationwide. Failed Dissolution Specifications: Product did not meet specification requirements for dissolution.
| Recall number | D-1091-2014 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Actavis Elizabeth LLC, Elizabeth, NJ, United States |
| Recall initiated | 2014-02-04 |
| Classified | 2014-02-28 |
| Reported by FDA | 2014-03-12 |
| Terminated | 2015-01-22 |
| Distributed | Nationwide (US) |
| Quantity | 5,148 bottles |
| Reason classes | specification failure |
| NDC | 00228-3086-06 |
| Lot numbers | 03/14, 57617531 |
Product
Alprazolam Extended-Release Tablets, USP, 3 mg, 60-count tablets per bottle, Rx only, Manufactured by: Actavis Elizabeth LLC, 200 Elmora Avenue, Elizabeth, NJ 07207, NDC 0228-3086-06, UPC 3 0228-3086-06 2.
Reason for recall
Failed Dissolution Specifications: Product did not meet specification requirements for dissolution.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-1091-2014. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.